Vascular Graft Solutions

About

Offices

Q&A

What is Vascular Graft Solutions' primary focus?

Vascular Graft Solutions is an Israeli company established in 2009, dedicated to improving coronary revascularization procedures through innovative medical technologies, specifically addressing challenges like vein graft disease in CABG surgery.

What is the total amount of funding Vascular Graft Solutions has raised to date?

Vascular Graft Solutions has raised a total of $10.7 million USD.

When did Vascular Graft Solutions receive CE Mark approval for its VEST product?

Vascular Graft Solutions received CE Mark approval for its VEST product in 2014.

When did Vascular Graft Solutions receive CE Mark approval for its FRAME product?

Vascular Graft Solutions received CE Mark approval for its FRAME product in late 2017.

What is the employee count for Vascular Graft Solutions?

Vascular Graft Solutions has 11-50 employees.

What was a significant development for Vascular Graft Solutions in January 2020?

In January 2020, Vascular Graft Solutions acquired the intellectual property developed by Kipsbay Medical Inc.

What is the status of VGS products in the United States and Canada?

Ongoing IDE-approved studies are being conducted in leading centers in the United States and Canada toward the commercialization of VGS products.

What is the primary sector of Vascular Graft Solutions?

Vascular Graft Solutions operates in the Health Tech & Life Sciences sector, specifically focusing on Medical Devices and Medical Treatment & Therapeutics.

Team · 6

Eyal Orion

Founder · Founder & Active Chairman

Elad Harf

CEO, VP M&S

Liad Yosef

VP Operations & Engineering

Dana Eshed

VP Legal

Orit Yarden

VP Clinical & Regulatory Affairs

Rachel Rosenstein

VP Quality Assurance

Sectors & technology

Highlights

Tags